Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Solid Tumors
NCT05359354
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
36
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor
Interventions
BIOLOGICAL:
Personalized neoantigen tumor vaccine
Sponsor
YueJuan Cheng
Collaborators
[object Object]